SPY326.54-3.44 -1.04%
DIA265.06-1.53 -0.57%
IXIC10,911.59-274.00 -2.45%

Morgan Stanley Downgrades MyoKardia to Equal-Weight, Raises Price Target to $225

Morgan Stanley analyst Jeffrey Hung downgrades MyoKardia (NASDAQ:MYOK) from Overweight to Equal-Weight and raises the price target from $121 to $225.

· 10/06/2020 10:27
Morgan Stanley analyst Jeffrey Hung downgrades MyoKardia (NASDAQ:MYOK) from Overweight to Equal-Weight and raises the price target from $121 to $225.